Literature DB >> 24299574

Appropriate timing for thyroidectomy scar treatment using a 1,550-nm fractional erbium-glass laser.

Kui Young Park1, In Young Oh, Seong Jun Seo, Kyung Ho Kang, Sung Jun Park.   

Abstract

BACKGROUND: Surgical scarring is a common cosmetic problem that occurs in various surgical fields, including dermatology. Many trials have been conducted to determine how to prevent this distressing scar formation. A 1,550-nm fractional erbium-glass laser has been used to improve the appearance of surgical scars, but an appropriate treatment time has not been established.
OBJECTIVES: To determine the appropriate time to apply 1,550-nm fractional erbium-glass laser treatment for thyroidectomy scars.
MATERIALS AND METHODS: Korean patients with linear surgical suture lines after thyroidectomy (N = 65) were treated using a 1,550-nm fractional erbium-glass laser. Patients were divided into three groups according to postoperative treatment time. Laser treatment was started in 40, 15, and 10 patients 3 weeks, 3 months, and 6 months postoperatively, respectively. Each patient was treated three times at 1-month intervals using the same parameters (14 mJ, 100 spots/cm(2) , 2 passes).
RESULTS: Mean Vancouver Scar Scale scores were significantly lower after laser treatment (p < .01), with the greatest difference in the group that began treatment 3 weeks postoperatively. Global assessment also indicated better cosmetic outcomes in the 3-week postoperative treatment group.
CONCLUSION: Early postoperative 1,550-nm fractional erbium-glass laser treatment of thyroidectomy scars is more effective than later treatment.
© 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24299574     DOI: 10.1111/dsu.12355

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  7 in total

1.  [Effect of CO₂ fractional laser on the early control of scar post-secondary repair in patients with a cleft lip].

Authors:  Yuan-Yuan Li; Min Wu; Ming-Xi Liu; Chen-Yang Xie; Qian Zheng; Bing Shi; Chen-Ghao Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

2.  Before-after cohort study to assess the efficacy of fractional ablative carbon dioxide laser treatment of pediatric hand scars.

Authors:  Huazhen Liu; Shisheng Chen; Xuwei Zhu; Zifu Zhou; Jin Zhang; Haiting Xu
Journal:  Lasers Med Sci       Date:  2020-11-09       Impact factor: 3.161

3.  Early intervention with pulse dye and CO2 ablative fractional lasers to improve cutaneous scarring post-lumpectomy: a randomized controlled trial on the impact of intervention on final cosmesis.

Authors:  Tamar Safra; Waseem Shehadeh; Amir Koren; Fares Salameh; Or Friedman; Eli Sprecher; Ofir Artzi
Journal:  Lasers Med Sci       Date:  2019-04-26       Impact factor: 3.161

4.  Comparison of the Effectiveness of Nonablative Fractional Laser versus Pulsed-Dye Laser in Thyroidectomy Scar Prevention.

Authors:  Ji Min Ha; Han Su Kim; Eun Byul Cho; Gyeong Hun Park; Eun Joo Park; Kwang Ho Kim; Lee Su Kim; Kwang Joong Kim
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

5.  The Important Factors Associated with Treatment Response in Laser Treatment of Facial Scars: A Single-Institution Based Retrospective Study.

Authors:  Youngkyoung Lim; Ji-Hye Park; Dong-Youn Lee; Na-Young Hwang; Soohyun Ahn; Jong Hee Lee
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

6.  Skin Wound Tension Reduction Device Combined with Ablative Fractional Carbon Dioxide Laser to Reduce Scar Formation After Excision of Pediatric Facial Skin Lesions: A Prospective Cohort Study.

Authors:  Haiting Xu; Jing Li; Zifu Zhou; Jianhai Bi; Xiaoyang Li; Ran Huo
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-22

7.  Low versus High Fluence Parameters in the Treatment of Facial Laceration Scars with a 1,550 nm Fractional Erbium-Glass Laser.

Authors:  Hyung-Sup Shim; Dai-Won Jun; Sang-Wha Kim; Sung-No Jung; Ho Kwon
Journal:  Biomed Res Int       Date:  2015-07-07       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.